Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
7 ‘Strong Buy' Dividend Kings to Grab Now in Case a Total Market Meltdown Is Coming
07:05am, Friday, 07'th Oct 2022
At 24/7 Wall St., we know how important dividend size, stability and growth are to growth and income investors who need a dependable stream of passive income.
Short-Term Treasury Rates Boost Appeal Of Bond ETFs
07:00am, Friday, 07'th Oct 2022
Funds investing in short-term Treasury bonds may be the best ETFs for investors in today's seesawing markets. The post Short-Term Treasury Rates Boost Appeal Of Bond ETFs appeared first on Investor's
Why Warren Buffett Thinks It's a Mistake to Dump Your Stocks in a Bear Market
02:30pm, Thursday, 06'th Oct 2022 The Motley Fool
Being out of the stock market may seem safer right now, but it is far from a risk-free strategy.
Why Warren Buffett Thinks It's a Mistake to Dump Your Stocks in a Bear Market
10:30am, Thursday, 06'th Oct 2022
Being out of the stock market may seem safer right now, but it is far from a risk-free strategy.
7 Safe Stocks to Buy and Hold Forever
09:45am, Thursday, 06'th Oct 2022
In this article, I'm giving long investors information about safe stocks to buy and hold for a long time; if not to own forever. Many investors haven't been through a bear market, much less one that i
Best Stocks 2022: What's Not to Like About AbbVie (ABBV) Stock?
02:15pm, Wednesday, 05'th Oct 2022
The stock market is rolling over as the third quarter comes to a close. The S&P 500 is down 21% year-to-date (YTD) as of this writing.
3 Dividend Stocks to Buy In October and Hold Forever
10:11am, Wednesday, 05'th Oct 2022 The Motley Fool
The payouts these companies distribute every quarter could surge over the next several years.
3 Dividend Stocks to Buy In October and Hold Forever
06:11am, Wednesday, 05'th Oct 2022
The payouts these companies distribute every quarter could surge over the next several years.
These Were The Five Best And Worst Performing Mega-Cap Stocks In September 2022
08:02pm, Tuesday, 04'th Oct 2022
September has historically been the weakest month for the U.S. stock market, and 2022 was no different.
3 Cheap Stocks to Buy for Their High Cash Flow and Dividends
05:39pm, Tuesday, 04'th Oct 2022
Living through bear markets sure can be tough. Such environments can create a lot of emotional turmoil, heartache and painful losses.
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
01:00pm, Tuesday, 04'th Oct 2022 Zacks Investment Research
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
Reata Pharma (RETA) is Striving Hard Despite Pipeline Setbacks
12:58pm, Tuesday, 04'th Oct 2022 Zacks Investment Research
Reata Pharmaceuticals (RETA) is yet to generate product revenues due to the lack of marketed drugs in its portfolio. However, two of its pipeline candidates are close to potential FDA approval.
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
10:32am, Tuesday, 04'th Oct 2022
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
Five Expected Dividend Increases In October 2022
11:40pm, Monday, 03'rd Oct 2022
Making sure that income stream grows is critical. Without growth, your dividend income stream will lose purchasing power to inflation.
Can AbbVie's (ABBV) New Drugs Make up for Lost Humira Sales?
01:35pm, Monday, 03'rd Oct 2022 Zacks Investment Research
AbbVie's (ABBV) new drugs, Skyrizi and Rinvoq, are faring well, bolstered by approval in new indications. They are expected to drive revenues once Humira loses U.S. exclusivity in 2023.
